fendiline has been researched along with Anemia, Sickle Cell in 1 studies
Fendiline: Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellory, JC | 1 |
| Nash, GB | 1 |
| Stone, PC | 1 |
| Culliford, SJ | 1 |
| Horwitz, E | 1 |
| Stuart, J | 1 |
1 other study available for fendiline and Anemia, Sickle Cell
| Article | Year |
|---|---|
Mode of action and comparative efficacy of pharmacological agents that inhibit calcium-dependent dehydration of sickle cells.
Topics: Anemia, Sickle Cell; Azepines; Bepridil; Calcium; Calcium Channel Blockers; Erythrocytes, Abnormal; | 1992 |